Mitral Valve Disease Articles & Analysis

1 news found

InnovHeart raises $55 million in Series C financing to further develop the Trans-septal Saturn Transcatheter Mitral Valve Replacement System

Milan, January 27, 2022 – InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral valve disease, announces the closing of its Series C financing with granting an exclusive licensing agreement to Grand Pharmaceutical Group Limited, (Grand ...

Jan. 27, 2022

ByInnovHeart Srl.

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you